Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-21-035331

See Remarks sold 28,118 shares at $28.95 ($814,016)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Zawel Leigh See Remarks 2021-09-07 Sale −28,118 $28.95 $814,016 65,406 D
Open-market sales · 28,118 sh · avg $28.95 · $814,016
Loading xslF345X03/doc4.xml…